Microchimerism in renal allografts: clinicopathological associations according to the type of chimeric cells
- PMID: 20102397
- DOI: 10.1111/j.1365-2559.2009.03466.x
Microchimerism in renal allografts: clinicopathological associations according to the type of chimeric cells
Abstract
Aims: Recent studies have highlighted the presence of microchimerism in various solid allografts. The biological significance of these chimeric cells is controversial. They may be beneficial, leading to better tolerance of grafts or participating in tissue repair or, in contrast, deleterious if involved in chronic lesions. The aim was to assess the frequency and cellular nature of microchimerism in female renal grafts of male recipients by combined fluorescence in situ hybridization (FISH) for Y chromosome and immunohistochemistry and to investigate associations between intragraft microchimerism and histological lesions or allograft outcome.
Methods and results: We screened 33 renal biopsy specimens, including 11 with acute T-cell-mediated rejection and nine with transplant glomerulopathy, from 22 male recipients transplanted with female kidneys by FISH and immunohistochemistry with antibodies against smooth muscle actin (mesangial cells), CD31 (endothelial cells), KL1 (epithelial cells), CD45 (leucocyte common antigen) and glomerular epithelial protein 1 (podocytes). Tubular microchimerism was detected in 71% of the patients with a mean percentage of chimeric epithelial cells of 1.4%. Glomerular microchimerism involving podocytes, mesangial and endothelial cells was present with a mean number of chimeric cells per glomerular section of, respectively, 0.6, 2.66 and 3.53. There was an association between endothelial microchimerism and a previous episode of acute T-cell-mediated rejection.
Conclusions: In conclusion, microchimerism in renal grafts occurs frequently, but at a low level and affects tubular cells and all glomerular cell compartments in human renal allografts.
Similar articles
-
Tubular and endothelial chimerism in renal allografts using fluorescence and chromogenic in situ hybridization (FISH, CISH) technology.Pathol Int. 2012 Apr;62(4):254-63. doi: 10.1111/j.1440-1827.2012.02803.x. Epub 2012 Mar 4. Pathol Int. 2012. PMID: 22449229
-
Does endothelial chimerism correlate with renal allograft rejection?Transplant Proc. 2006 Dec;38(10):3430-3. doi: 10.1016/j.transproceed.2006.10.154. Transplant Proc. 2006. PMID: 17175294
-
Endothelial cell chimerism by fluorescence in situ hybridization in gender mismatched renal allograft biopsies.Chin Med J (Engl). 2007 May 20;120(10):859-62. Chin Med J (Engl). 2007. PMID: 17543173
-
Acute kidney graft rejection morphology and immunology.APMIS Suppl. 1997;67:1-35. APMIS Suppl. 1997. PMID: 9063492 Review.
-
Glomerular epithelial cells in the urine: what has to be done to make them worthwhile?Am J Physiol Renal Physiol. 2009 Feb;296(2):F230-41. doi: 10.1152/ajprenal.90507.2008. Epub 2008 Oct 8. Am J Physiol Renal Physiol. 2009. PMID: 18842819 Review.
Cited by
-
Low-dose tacrolimus combined with donor-derived mesenchymal stem cells after renal transplantation: a prospective, non-randomized study.Oncotarget. 2016 Mar 15;7(11):12089-101. doi: 10.18632/oncotarget.7725. Oncotarget. 2016. PMID: 26933811 Free PMC article. Clinical Trial.
-
Endothelial cell provenance: an unclear role in transplant medicine.Front Transplant. 2023 Apr 28;2:1130941. doi: 10.3389/frtra.2023.1130941. eCollection 2023. Front Transplant. 2023. PMID: 38993867 Free PMC article. Review.
-
Chimerism in women with end stage renal diseases: Who's who?Chimerism. 2012 Apr-Jun;3(2):48-50. doi: 10.4161/chim.21475. Epub 2012 Apr 1. Chimerism. 2012. PMID: 22854596 Free PMC article.
-
Advanced flow cytometric detection of endothelial cell chimerism in kidney transplants.Nephrol Dial Transplant. 2023 Dec 20;39(1):163-166. doi: 10.1093/ndt/gfad159. Nephrol Dial Transplant. 2023. PMID: 37458795 Free PMC article. No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous